Targeting strategies of oral nano-delivery systems for treating inflammatory bowel disease
- 1 May 2021
- journal article
- review article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 600, 120461
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
This publication has 123 references indexed in Scilit:
- Biological hydrogels as selective diffusion barriersTrends in Cell Biology, 2011
- Selective nanoparticle adhesion can enhance colitis therapyNature Reviews Gastroenterology & Hepatology, 2010
- Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissuesAdvanced Drug Delivery Reviews, 2009
- The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteriaProceedings of the National Academy of Sciences, 2008
- Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn’s diseaseInternational Journal Of Clinical Practice, 2008
- Azo compounds in colon-specific drug deliveryExpert Opinion on Drug Delivery, 2007
- Unravelling the pathogenesis of inflammatory bowel diseaseNature, 2007
- Comparative study of the intestinal mucus barrier in normal and inflamed colonGut, 2007
- Very low intraluminal colonic pH in patients with active ulcerative colitisDigestive Diseases and Sciences, 1993
- Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis.Gut, 1993